India makes its mark in the emerging markets
The fast-growing markets of Africa and the Middle East remained a focal point for Indian firms on a global mission.
Pharma sector makes its mark on the world
Some of India’s leading pharmaceutical majors made their mark with acquisitions in recent months.
Aurobindo Pharma buys Portugal firm
Aurobindo PharmaceuticalsAurobindo Pharma has announced the acquisition of Portugal’s Generis Farmaceutica SA.
The Hyderabad-based company said a definitive agreement was signed by its step-down subsidiary, Agile Pharma, Netherlands. The acquisition will be from Magnum Capital Partners for an all-cash deal, the company said.
It will include a manufacturing facility in Amadora, Portugal, which has the capacity to produce 1.2 billion tablets or capsules annually. After the acquisition, the Aurobindo Group will be the largest in the generic pharmaceutical market in Portugal, with a portfolio of 271 generic products.
Generis has a wide portfolio of products, with a major share in therapeutic areas such as cardiovascular, central nervous system, anti-infective, and the genitourinary system.
Aurobindo expects to complete the deal by next month, after the Portuguese Competition authorities clear the deal.
Pharma, tech lead boost in India-UK ties
Pharmaceutical and technology sectors were in the lead as Indian companies continued their UK expansion drive.
Romancing the Bear
India-Russia ties have been rooted in history but 2016 marked a shift in gears to give the relationship a solid 21st century dimension. President Vladimir Putin’s visit to India in October marked a boost for the Make in India programme with the signing of a slew of deals for the co-production of military helicopters. India also signed up to the purchase of Russian missiles and frigates. Some highlights of the joint statement issued by Prime Minister Narendra Modi and Putin [...]
India’s Top 50 Outbound Investments 2016
Indian companies – big corporates and smaller and medium enterprises – made considerable strides this year. ‘India Global Business’ reviews some of the progress in this deal tracker. 1. Aurobindo Pharma makes French move India’s Aurobindo Pharma Ltd will be acquiring select commercial products from Israel’s Teva through its French subsidiary. Arow Generiques SAS (Arrow Generiques) will acquire the right, title and interest in products such as calcium and calcium vitamin D3, including the use of the OROCAL trademark. The [...]
Indian pharma firm acquires UK’s Actavis to beat Brexit gloom
Beats Mylan, Novartis, Torrent, Aurobindo to the post. Promoter says hungry for more
Almost inarguably, October 5th 2016, a Wednesday was the biggest day in the life of 53 year old Binish Hasmukh Chudgar, the highly low profile vice chairman of Ahmedabad based Intas Pharmaceuticals. That day in central London, Intas snapped up Israeli generic drug maker Teva’s assets in UK and Ireland—Actavis UK Ltd and Actavis Ireland Ltd—in a record $ 764 million deal (Rs 5083 crore) out muscling bigger global rivals like Mylan and Novartis or domestic competition like Aurobindo pharma and Torrent Pharmaceuticals in a bidding process that lasted over 6 months.
India makes its mark in the US market
From ICT to pharmaceuticals, Indian firms have made some major strides in the American market in recent months.
India firm on US expansion drive
As the hyperbole around the US presidential elections builds up, ‘India Global Business’ tracks some of Indias recent expansion drive in the country.
Reasons why India is the pharmacy to the world
The life-saving role played by Indian pharmaceutical firms in poorer countries of Africa is one of the real global success stories of our time. The year: 2001. Africa was facing a major health crisis. Sub-Saharan Africa alone had 22.5 million HIV-positive people. The disease was assuming epidemic proportions. The price of patented drugs supplied by western drug companies was a prohibitive $10,000 per patient per year – way out of reach of the average patient. Enter Cipla, an Indian pharmaceutical [...]
From a distant outpost to strategic Act East partners
India’s rising global profile, its increasing integration into the global economy and expanding geo-political interests are changing the profile of ANZ – from a distant outpost somewhere in the southern hemisphere with hard to beat cricketers and harder to understand accents, these countries have suddenly emerged as important economic, strategic and military partners in India’s Act East initiative. Australia and New Zealand (ANZ) have, traditionally, figured in the Indian consciousness only during cricket matches. Most Indians aren’t very clear about [...]